武警医学2017，Vol.28Issue(1)：72-74,3.
复方倍他米松联合透明质酸钠在退行性半月板损伤手术中的应用
Therapeutic effect of compound betamethasone combined with sodium hyaluronate on degenerative meniscus injury
葛茂林 1王晓红 2云文科 2任娜1
作者信息
- 1. 010040 呼和浩特,武警内蒙古总队医院外二科
- 2. 010040 呼和浩特,武警内蒙古总队医院院部
- 折叠
摘要
Abstract
Objective To evaluate the efficacy of compound betamethasone combined with sodium hyaluronate in the treatment of degenerative meniscus injury.Methods Forty-nine patients with degenerative meniscus injury (observation group) were treated with compound betamethasone combined with sodium hyaluronate in our hospital from Jan 2014 to Dec 2015.Another 45 patients with degenerative meniscus injury (control group) had been treated with simple sodium hyaluronate injection between June 2012 and December 2013.The therapeutic effect of the two groups was observed.Results The total effective rate(93.9％) in the observation group was better than that (82.2％) in the control group (P ＜ 0.05).There was no statistical differences in the IKDC score between the two groups before the treatment (P ＞ 0.05).After 6 months,the IKCK score (76.1 ± 9.8) in the observation group was better than that (61.9 ± 7.7) in the control group(P ＜ 0.05).There was no significant difference in Lysholm score between the two groups before the treatment (P ＞ 0.05).After 6 months of treatment,the Lysholm score (87.8 ± 8.6) in the observation group was significantly higher than that (71.1 ±6.9)in the control group (P ＜0.05).After 6 months,The levels of serum NO and IL-1β in control group and observation group were significantly lower than before the treatment (P ＜ 0.05).The levels of NO and IL-1 β inobservation groupwas better than that in control group (P ＜ 0.05).Conclusions Compound betamethasone combined with sodium hyaluronate is superior to sodium hyaluronate alone in the treatment of degenerative meniscus injury.关键词
复方倍他米松/透明质酸钠/退行性半月板损伤Key words
compound betamethasone/sodium hyaluronate/degenerative meniscus injury分类
医药卫生引用本文复制引用
葛茂林,王晓红,云文科,任娜..复方倍他米松联合透明质酸钠在退行性半月板损伤手术中的应用[J].武警医学,2017,28(1):72-74,3.
